Avient (AVNT) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
9 Jul, 2026Executive summary
Sales rose to $815 million in Q3 2024, up 8–8.5% year-over-year, with broad-based growth across all regions and most end markets, led by consumer, packaging, healthcare, defense, and building/construction; telecom and transportation remained weak.
Adjusted EPS increased 14% to $0.65, exceeding guidance, while adjusted EBITDA grew 6% to $130 million; GAAP EPS from continuing operations was $0.41, up from $0.06.
Both Color, Additives and Inks (CAI) and Specialty Engineered Materials (SEM) segments delivered organic revenue growth and margin expansion, supported by market share gains, new product launches, and restocking.
Dividend increased 5% to $1.08 annualized, marking the fourteenth consecutive annual increase.
Refinanced $650 million in senior notes, extending maturity to 2031 at 6.25%, and reduced interest expense through debt paydown and term loan repricing.
Financial highlights
Net sales reached $815 million (+8–8.5% YoY); adjusted EBITDA was $130 million (+6% YoY); adjusted EPS was $0.65 (+14% YoY); gross margin improved to 32.1%.
Operating income for Q3 was $77.2 million, more than double the prior year; net income from continuing operations was $38.2 million.
Adjusted EBITDA margin was 15.9% in Q3 2024, compared to 16.3% in Q3 2023.
Dividend per share for Q3 was $0.2575, up from $0.2475 in the prior year quarter.
Cash and cash equivalents at quarter-end were $505.7 million; liquidity was $739.1 million.
Outlook and guidance
Full-year 2024 adjusted EBITDA guidance narrowed to $525–$530 million; adjusted EPS guidance set at $2.63–$2.67, representing 11–13% growth over prior year.
Q4 adjusted EPS expected in the range of $0.46–$0.50, including a $15 million ($0.12/share) headwind from variable compensation accruals.
Interest expense for the year expected at $104 million; capital expenditures and S/4 Hana investment at ~$140 million.
Management expects sufficient liquidity for the next twelve months and foreseeable future.
Continued strong demand anticipated in consumer, packaging, healthcare, defense, and building/construction; transportation and telecom expected to remain weak.
Latest events from Avient
- FY06 earnings rebounded, but 2007 margin gains faced soft demand and chlorovinyl headwinds.AVNT
Q4 2006 - Debt fell after the OxyVinyls sale, but weak construction and remediation charges depressed 2007 earnings.AVNT
Q4 2007 - Late-year demand collapse and large one-time charges turned modest sales growth into a $272.9M loss.AVNT
Q4 2008 - Operating income recovered to $98.4M as cash strengthened despite a 24.8% sales decline.AVNT
Q4 2009 - Volume recovery and efficiency lifted FY2010 results, while tax and one-time gains boosted net income.AVNT
Q4 2010 - FY11 growth met a pension-driven Q4 operating loss and major portfolio changes.AVNT
Q4 2011 - Record adjusted EPS and a specialty-led mix shift offset soft markets and lower reported earnings.AVNT
Q4 2012 - Acquisitions drove FY13 growth, alongside a major divestiture gain and integration costs.AVNT
Q4 2013 - Record adjusted EPS and stronger specialty mix offset restructuring and pension charges.AVNT
Q4 2014 - Adjusted EPS rose 9%, as specialty growth offset revenue and DSS headwinds.AVNT
Q4 2015